Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217332 · ClinicalTrials.gov registry record · Phase 2
Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
A Phase 2 study, sponsored by Knopp Biosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02217332: Completed Phase 2 study, sponsored by Knopp Biosciences.
NCT02217332 is a Phase 2 study that has completed, run by Knopp Biosciences. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217332, a Phase 2 study, has completed, sponsored by Knopp Biosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Phase 2, open-label, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 6 months in subjects with chronic sinusitis with nasal polyps and eosinophilia.
Primary Outcome
Change in peripheral blood eosinophil (measured in cells/μL) from baseline to month 6 is presented as ratio to baseline.
Interventions
- DRUG dexpramipexole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-01-20 |
| Phase | Phase 2 |
What the finished NCT02217332 record still lists
NCT02217332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which dexpramipexole is the first listed.
NCT02217332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02217332 about?
NCT02217332 is a clinical study titled "Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia". Phase 2, open-label, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 6 months in subjects with chronic sinusitis with nasal polyps and eosinophilia.
What is the current status of trial NCT02217332?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-08. Estimated completion is 2017-01-20.
What interventions are being tested in trial NCT02217332?
The interventions under investigation include: dexpramipexole (DRUG).
Who is sponsoring clinical trial NCT02217332?
This trial is sponsored by Knopp Biosciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02217332's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia